Big pharma and the UK Government.

Abstract Vol 367 January 14, 2006 97 14 Ministry of Defence. Historical survey of the Porton Down Service Volunteers Programme. Feb 21, 2002: volunteers/survey.htm (accessed July 9, 2005). 15 Wellcome Trust. Death of a serviceman: will a study of a 50-year old death help us safeguard medical ethics in these troubled times? http://www. (accessed June 25, 2005). 16 Lee HA, Gabriel R, Bale AJ, Welch D. Clinical findings in 111 ex-Porton volunteers. J R Army Med Corps 2004; 150: 14–19. 17 Medical Research Council. Porton Down update February 2004. London: MRC, 2004. 18 Page WF. Long-term health effects of exposures to sarin and other anticholinesterase chemical warfare agents. Mil Med 2003; 168: 239–45. 19 Institute of Medicine. Gulf war and health: updated literature review of sarin. Washington, DC: Institute of Medicine, 2004. 20 Li Q, Hirata Y, Kawada T, Minami M. Elevated frequency of sister chromatid exchanges of lymphocytes in sarin-exposed victims of the Tokyo disaster 3 years after the event. Toxicology 2004; 201: 209–10. 21 Abou-Donia MB. Organophosphorus ester-induced chronic neurotoxicity. Arch Envir Health 2003; 58: 484–97. 22 Ohbu S, Yamashina A, Takasu N, et al. Sarin poisoning on Tokyo subway. South Med J 1997; 90: 687–93. 23 Ohtani T, Iwanami A, Kasai K, et al. Post-traumatic stress disorder symptoms in victims of Tokyo subway attack: a 5-year follow-up study. Psychiatry Clin Neurosci 2004; 58: 624–29. 24 Tochigi M, Otani T, Yamasue H, et al. Support for the relationship between serum cholinesterase and post-traumatic stress disorder; 5-year follow-ups of victims of the Tokyo subway sarin poisoning. Neurosci Res 2005; 52: 129–31. 25 Ministry of Defence. Review of modelling of the demolitions at Khamisiyah in March 1991 and implications for UK personnel. Jan 27, 2005: http://www. (accessed June 25, 2005). 26 Smith TC, Gray GC, Weir JC, Heller JM, Ryan MA. Gulf War veterans and Iraqi nerve agents at Khamisiyah: postwar hospitalization data revisited. Am J Epidemiol 2003; 158: 457–67.

Cite this paper

@article{Collier2006BigPA, title={Big pharma and the UK Government.}, author={Joe Collier}, journal={Lancet}, year={2006}, volume={367 9505}, pages={97-8} }